These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 34931282

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Population pharmacokinetics/pharmacodynamics of micafungin against Candida species in obese, critically ill, and morbidly obese critically ill patients.
    Maseda E, Grau S, Luque S, Castillo-Mafla MP, Suárez-de-la-Rica A, Montero-Feijoo A, Salgado P, Gimenez MJ, García-Bernedo CA, Gilsanz F, Roberts JA.
    Crit Care; 2018 Apr 15; 22(1):94. PubMed ID: 29655372
    [Abstract] [Full Text] [Related]

  • 25. Population Pharmacokinetics and Target Attainment of Meropenem in Plasma and Tissue of Morbidly Obese Patients after Laparoscopic Intraperitoneal Surgery.
    Wittau M, Scheele J, Kurlbaum M, Brockschmidt C, Wolf AM, Hemper E, Henne-Bruns D, Bulitta JB.
    Antimicrob Agents Chemother; 2015 Oct 15; 59(10):6241-7. PubMed ID: 26248353
    [Abstract] [Full Text] [Related]

  • 26. Population pharmacokinetics of piperacillin in the early phase of septic shock: does standard dosing result in therapeutic plasma concentrations?
    Öbrink-Hansen K, Juul RV, Storgaard M, Thomsen MK, Hardlei TF, Brock B, Kreilgaard M, Gjedsted J.
    Antimicrob Agents Chemother; 2015 Nov 15; 59(11):7018-26. PubMed ID: 26349823
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC.
    Dan Med J; 2013 Nov 15; 60(11):B4698. PubMed ID: 24192246
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Population Pharmacokinetics of Teicoplanin in Preterm and Term Neonates: Is It Time for a New Dosing Regimen?
    Kontou A, Sarafidis K, Begou O, Gika HG, Tsiligiannis A, Ogungbenro K, Dokoumetzidis A, Agakidou E, Roilides E.
    Antimicrob Agents Chemother; 2020 Mar 24; 64(4):. PubMed ID: 31932366
    [Abstract] [Full Text] [Related]

  • 32. Caspofungin pharmacokinetics and probability of target attainment in ICU patients in China.
    Li F, Zhou M, Jiao Z, Zou Z, Yu E, He Z.
    J Glob Antimicrob Resist; 2021 Jun 24; 25():238-263. PubMed ID: 33845162
    [Abstract] [Full Text] [Related]

  • 33. Development of breakpoints of cephems for intraabdominal infections based on pharmacokinetics and pharmacodynamics in the peritoneal fluid of patients.
    Ikawa K, Morikawa N, Ikeda K, Ohge H, Sueda T.
    J Infect Chemother; 2008 Apr 24; 14(2):141-6. PubMed ID: 18622678
    [Abstract] [Full Text] [Related]

  • 34. Vancomycin population pharmacokinetics for adult patients with sepsis or septic shock: are current dosing regimens sufficient?
    Heffernan AJ, Germano A, Sime FB, Roberts JA, Kimura E.
    Eur J Clin Pharmacol; 2019 Sep 24; 75(9):1219-1226. PubMed ID: 31154476
    [Abstract] [Full Text] [Related]

  • 35. Using Population Pharmacokinetic Modeling and Monte Carlo Simulations To Determine whether Standard Doses of Piperacillin in Piperacillin-Tazobactam Regimens Are Adequate for the Management of Febrile Neutropenia.
    Sime FB, Hahn U, Warner MS, Tiong IS, Roberts MS, Lipman J, Peake SL, Roberts JA.
    Antimicrob Agents Chemother; 2017 Nov 24; 61(11):. PubMed ID: 28807922
    [Abstract] [Full Text] [Related]

  • 36. First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis.
    Roberts JA, Kirkpatrick CM, Roberts MS, Dalley AJ, Lipman J.
    Int J Antimicrob Agents; 2010 Feb 24; 35(2):156-63. PubMed ID: 20018492
    [Abstract] [Full Text] [Related]

  • 37. What is the optimal loading dose of broad-spectrum β-lactam antibiotics in septic patients? Results from pharmacokinetic simulation modelling.
    Delattre IK, Hites M, Laterre PF, Dugernier T, Spapen H, Wallemacq PE, Jacobs F, Taccone FS.
    Int J Antimicrob Agents; 2020 Oct 24; 56(4):106113. PubMed ID: 32721604
    [Abstract] [Full Text] [Related]

  • 38. Pharmacodynamic evaluation of biapenem in peritoneal fluid using population pharmacokinetic modelling and Monte Carlo simulation.
    Ikawa K, Morikawa N, Ikeda K, Ohge H, Sueda T.
    Int J Antimicrob Agents; 2008 Oct 24; 32(4):339-43. PubMed ID: 18602798
    [Abstract] [Full Text] [Related]

  • 39. Population pharmacokinetics of meropenem in patients undergoing automated peritoneal dialysis.
    Ullah S, Ursli M, Fuhr U, Wiesholzer M, Kussmann M, Poeppl W, Zeitlinger M, Taubert M.
    Perit Dial Int; 2023 Sep 24; 43(5):402-410. PubMed ID: 37131320
    [Abstract] [Full Text] [Related]

  • 40. Fluconazole dosing predictions in critically-ill patients receiving prolonged intermittent renal replacement therapy: a Monte Carlo simulation approach.
    Gharibian KN, Mueller BA.
    Clin Nephrol; 2016 Jul 24; 86(7):43-50. PubMed ID: 27251341
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.